tm logo

Monitor this mark

View On USPTO

SYMDEKO
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 01 Nov 2023

Last Applicant/ Owned by

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston

MA

02210

Serial Number

87504249 filed on 25th Jun 2017

Registration Number

5460641 registered on 01st May 2018

in the Principal Register

Correspondent Address

Kelli A. Ovies

Kelli A. Ovies

555 Fayetteville Street, Suite 1100

Raleigh NC 27601

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SYMDEKO

Pharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of cystic fibrosis

First Use Date in General

14th Feb 2018

First Use Date in Commerce

14th Feb 2018

Specimens

SYMDEKO specimenSYMDEKO specimen

Mark Details

Serial Number

No 87504249

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.07.07 -

Prize ribbons

26.01.21 -

Circles that are totally or partially shaded

26.01.31 -

Five or more circles

26.17.12 -

Chevrons and angles

Legal History

Show more

Status DateAction Taken
01st Nov 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Nov 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01st Nov 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03rd May 2023TEAS SECTION 8 & 15 RECEIVED
01st May 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01st May 2018REGISTERED-PRINCIPAL REGISTER
27th Mar 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
25th Mar 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06th Mar 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
06th Mar 2018STATEMENT OF USE PROCESSING COMPLETE